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Introduction 
The purpose of bone void fillers, besides filling a bone defect, is 
to encourage new bone growth by providing structural support for 
blood clotting and bone remodelling [1]. Ideally, the bone void filler 
should be resorbed and replaced through sequential remodelling cycles 
that are synchronised with the natural remodelling process. This will 
ensure that mechanical stability and metabolic function are maintained 
at the defect site and minimise the risk of failure from infection [2,3]. 
Over recent years, an increasing number of synthetic bone substitutes 
have become clinically available as alternatives to traditional graft 
materials [4,5]. Despite this, clinicians preferentially choose autologous 
bone graft, as synthetic alternatives still fail to match their in vivo 
performance [6,7]. 
The majority of synthetic bone void fillers tend to be HA, or 
related CaP ceramics, due to their similarity to bone mineral, which is 
approximately 60% HA by weight [8]. Research into naturally derived 
and synthetic CaP bone void fillers has focused mainly on the design 
and regulation of material properties to augment tissue regeneration. 
In more recent years, the focus has shifted towards the “intelligent 
biomaterial” which delivers active pharmacological compounds and/
or biological entities, such as morphogenic proteins, genes and growth 
factors, to enhance and accelerate regeneration [9]. 
There is, however, still a lack of understanding of critical 
physicochemical factors, which influence specific biological responses. 
For example, the role of microscale (0.5 - 10µm) and macroscale 
(>100µm) porosity to induce ectopic bone formation [10,11]. It has been 
well established that macroporosity with pores and interconnections 
>100µm improves osteogenic outcomes [12]. The role of microporosity 
and/or multi-scale porosity in osteogenesis is still not clear. Several 
studies have reported the negative effects of microporosity with regard 
to fibrous ingrowth, reduced cell viability and restricted cell ingrowth 
[13,14]. Other more recent in vivo studies, however have clearly 
found that microporosity enhances bone regeneration by modulating 
osteogenic differentiation [15,16], enhancing mechanical properties 
with more efficient load transfer [17], and improving bioresorption 
[18].      
Mineralised biological tissues in nature, such as bone, teeth, 
mollusk shells, and coral, have shown that hierarchical structures 
with interconnected meso (2 – 50nm), micro (0.5 - 10µm) and macro 
(>100µm) pores are crucial to biological function 19]. The ability to 
replicate these hierarchical structures in purely synthetic biomaterials 
has proven to be one of the most demanding manufacturing challenges 
in the field. Several techniques exist to produce porous bioceramics; 
but techniques to produce interconnected porous structures are much 
more limited. Templating is the only manufacturing technique that 
has shown any real potential, however it relies heavily on the existence 
of suitable templates [20,21] - those currently investigated include 
polymer foams, hydrogels, emulsions, composites on block copolymer 
and surfactants, bovine bone, marine sponges and corals [20,22]. 
Pro-OsteonTMand Biocoral® are two coral-derived commercially 
available products currently on the market. These materials have been 
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Abstract
Macroporosity(>100µm) in bone void fillers is a known prerequisite for tissue regeneration, but recent literature 
has highlighted the added benefit of microporosity(0.5 - 10µm). The aim of this study was to compare the in vitro 
performances of a novel interconnective microporous hydroxyapatite (HA) derived from red algae to four clinically 
available macroporous calcium phosphate (CaP) bone void fillers. The use of algae as a starting material for this 
novel void filler overcomes the issue of sustainability, which overshadows continued use of scleractinian coral in the 
production of some commercially available materials, namely Pro-OsteonTM and Bio-Coral®. This study investigated 
the physicochemical properties of each bone voidfiller material using x-ray diffraction, fourier transform infrared 
spectroscopy, inductive coupled plasma, and nitrogen gas absorption and mercury porosimetry. Biochemical 
analysis, XTT, picogreen and alkaline phosphatase assays were used to evaluate the biological performances of the 
five materials. Results showed that algal HA is non-toxic to human foetal osteoblast (hFOB) cells and supports cell 
proliferation and differentiation. The preliminary in vitro testing of microporous algal-HA suggests that it is comparable 
to the four clinically approved macroporous bone void fillers tested. The results demonstrate that microporous algal 
HA has good potential for use in vivo and in new tissue engineered strategies for hard tissue repair.
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used clinically for more than 10 years and have performed similarly to 
other synthetic bone void fillers, exhibiting limited osteoinductivity in 
vivo [23,24]. The main benefit of coral-derived bone void fillers over 
synthetic alternatives is their bioresorption capacity [25,26]. Recently, 
other sustainable calcified marine structures and organisms, such 
as mussels [27, cuttlefish bone [28] and algae [26,29,30] have been 
investigated for bone void filler applications.
The aim of this study was to evaluate microporous 
(0.5 - 10µm) marine-based bioceramic granules (QUB 
HA) in comparison to other more macroporous (>100µm) 
bovine (Bio Oss), synthetic (Bone Save) and marine-based 
(Pro–Osteon™) commercial bioceramic granules. Our hypothesis 
is that the microporous granules will perform just as well as those 
with macroporosity in terms of the biological response. Each of 
these products has been manufactured differently [31-33], giving 
them a unique set of physicochemical attributes (Table 1). In this 
initial study, the physicochemical properties were studied using a 
wide range of analytical techniques [x-ray diffraction (XRD), fourier 
transform infrared spectroscopy (FTIR), inductive coupled plasma-
mass spectrometry (ICP-MS), nitrogen gas absorption (SBET), mercury 
intrusionporosimetry (MIP)] to obtain a comprehensive overview of 
each material and preliminary in vitro testing of cell attachment, cell 
death, proliferation and differentiation. 
Materials and Methods  
Materials 
Corallinaofficinalis was harvested from Fanad, Co. Donegal. It was 
processed into a biphasic calcium phosphate microporous bioceramic 
(QUB HA) by a low temperature-pressure synthesis technique reported 
previously [34,35]. Briefly, the algae samples were cleaned using: sodium 
hypochlorite (NaOCl; 0.1M), hydrogen peroxide (H2O 2; 30  wt. % in 
H2O) and sodium hydroxide (NaOH, 0.5M), to remove macroscopic 
dirt/impurities; then heat treated to isolate the inorganic compound. 
Heat treatment resulted in the partial conversion of algae from Mg-
rich-calcite to calcium oxide [36]. For synthesis, a stoichiometric ratio 
(Ca/P=1.67) of heat treated algae was added to a 2 molar
Diammonium hydrogenphosphate (99.9%; Sigma Aldrich) aqueous 
solution. The pH was adjusted in the range of 10-12 with ammonium 
hydroxide (28% in H 2O, Sigma Aldrich) and maintained throughout 
synthesis. The suspension was heated to 100°C in an open system 
reaction vessel under constant agitation for 12hrs. It was then cooled 
and aged for 24hrs at room temperature. The residual phosphate was 
removed by soaking the granules in 10% v/v CH3COOH for 1 hr under 
agitation, which effectively removes the residual phosphate without 
dissolving synthesised phosphate[34,35]. The resultant granules were 
washed in dH2O until the wash solution reached a pH ~ 7, filtered and 
dried overnight at 90°C. Four different clinically available bone void 
filler materials were evaluated: 1) Bio Oss, GeistlichPharma; 2) Bone 
Save, Stryker Osteonics; 3) Pro–Osteon™ 200R and 4) Pro–Osteon™ 
500R, Biomet (Interpore) and compared to QUB HA. 
Material characterization  
Scanning Electron Microscopy (SEM) / Image Analysis (IA): 
SEM coupled with IA was used to determine pore size within the bone 
void filler materials. Granules were dispersed on the surface of an 
aluminium SEM stub coated with Araldite epoxy glue and then sputter 
coated with gold. Micrograph images were taken on a JEOL 6500 SEM 
microscope and imported into imaging software (Lucia). Manual 
point-to-point (n=20) measurements were taken in each direction to 
determine the pore size, per image with 3 replications.    
Nitrogen gas absorption (SBET): The specific surface areas, 
m2 g−1(SBET ), of the granules were determined using nitrogen adsorption 
isotherms measured on a FisonsSorptomatic 1900 analyser. The areas 
were calculated using Brunauer, Emmett and Teller (BET) multilayer 
method (QuantachromeTM NovaWin2 software). Before analysis, the 
granules were outgassed at -73K for 24hrs.   
Mercury intrusion porosimetry (MIP): A mercury porosimeter 
(QuantachromePoremaster) with a small penetrometer was used to 
determine the porosity of the bone void filler materials. Samples (0.2–
0.4gs) were analysed with a contact angle of 140º and surface tension 
of 480.00 ergcm-2.The theoretical porosity was calculated from the total 
intrusion volume. 
Inductively coupled plasma-mass spectrometry (ICP-MS)
Elemental analysis was performed to determine Ca, P and Mg 
concentrations to calculate the Ca/P and Ca+Mg/P molar ratios using 
a Perkin Elmer Optical Emission Spectrometer, Optima 4300DV. Prior 
to analysis the machine was calibrated to 10ppm with a detection limit 
of 0.01mg L-1.  Powdered samples were digested in 2%v/v nitric acid 
(ACS reagent, ISO, ≥69%) in dH2O overnight and then diluted within 
the detection limit of the machine for analysis.    
Powder X-ray diffraction (XRD): The bulk chemical composition 
of the materials was determined using XRD. Powder diffraction 
scans were recorded at room temperature using an X-Pert Pro 
X-ray diffractometer system with an X’Celerator X-ray detector 
(PANanlyticalX’Pert PRO MPD; Model No. 135 PW3040/60) and 
CuKα radiation. For phase identification, a step size of 0.02 and count 
rate of 0.0005 min-1 were used to obtain the spectra for between 10 and 
70° (2°θ). Scans were imported into X-Pert high score for analysis with 
reference data, then characterised using Rietveld refinement analysis. 
Fourier Transform Infra-Red spectroscopy (FTIR) : FTIR was 
used to identify functional groups on the surface of the bone void 
filler materials. IR spectra were recorded on a Perkin-Elmer 1600 
M-80 spectrometer. Spectra of powdered samples were collected in 
transmission mode from 124 scans, over a frequency range of 400 to 
4400cm-1, at a resolution of 4cm-1. 
Biological characterization 
Cell culture: Cell culture experiments were performed using a 
transformed human fetal osteoblast (hFOB) cell line (LGC/ATCC, 
UK). Cells were cultured in DMEM/F-12 medium supplemented 
with 10% fetal bovine serum (FBS), 0.3mgml-1geneticin and 200mM 
L-glutamine (all Invitrogen, UK).50  μM ascorbate-2-phosphate 
(Sigma,UK) was also added to the medium for the alkaline phosphatase 
(ALP) experiment only. All assays were incubated in 5% CO2 in air at 
the permissive (proliferative) temperature of 33°C (unless otherwise 
stated). All materials were sterilized by autoclaving at 121°C for 30 
minutes in their original granular form. For each experiment,100 to 
120mg/well (≈ 80%) of a 96-well plate was evenly covered in bone void 
filler granules and then pre-wetted in culture medium for 24hrs. Before 
seeding, the medium was removed and granules were washed twice in 
phosphate-buffer saline (PBS). In each assay, the granules and tissue 
culture polystyrene (TCP) without granules (control) were seeded 
with hFOBs at a density of 1x105 cellscm-2 and fed bi-weekly with 
the appropriate medium. There were six replicates per experimental 
condition (n=6) and for each assay readings were performed in 
duplicate for each well.   
Cytotoxicity: Cytotoxicity was measured after 72hrs incubation 
using a CytoTox96 non-radioactive assay (Promega) according to the 
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manufacturer’s instructions.This assay measures lactate dehydrogenase 
in the culture supernatant. Absorbance was read at a wavelength of 
450nm with a reference wavelength of 620 on a GENios plate reader 
(TECAN, Theale, U.K.)
Cell viability: Cell viability was observed colorimetrically at 1, 3 
and 7 days using an XTT assay (In vitro Toxicology Assay Kit, TOX2, 
and Sigma). Viability wasdetermined by the ability of metabolically 
active cells to reduce tetrazolium salts (2, 3-bis [2-Methoxy-4-nitro-5-
sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt) to an orange 
formazan dye. The reagent was prepared according to manufacturer’s 
instructions and a volume equal to 20% of the culture medium was 
added to each well. After 4 hrs incubation at 33°C, 50µl aliquots were 
transferred in duplicate to a fresh 96-well plate and absorbance read at 
a wavelength of 450nm with a reference wavelength of 620nm. Average 
absorbance values from medium-only wells were subtracted from net 
absorbance values (620 - 450nm) for each experimental group. 
Cell proliferation: Cell proliferation was determined by 
measuring the DNA content of cell lysates using a PicoGreen®dsDNA 
Quantification Kit (Invitrogen). At each time point (1, 3 and 7 days) 
the culture medium was replaced with 0.1%v/v Triton X-100 in PBS 
and frozen at -80°C. Cells were lysed by three freeze/thaw cycles and 
the assay performed as per manufacturer’s instructions. Samples were 
analysed at wavelengths of 480nm (excitation) and 520nm (emission).
Cell differentiation: ALP enzymatic activity was used as a maker 
of cell differentiation. ALP activity was measured using the substrate 
p-nitrophenyl phosphate (Sigma-Aldrich, UK) in an end-point 
assay. After seeding hFOBs onto each material in complete medium 
supplemented with ascorbate-2-phosphate, cells were incubated at 
33°C for 24hrs, followed by incubation at the restrictive (differentiating) 
temperature of 39°C for a further 3 and 7 days. Cells were lysed as 
described in section 2.3.4 and 50l aliquots were added in duplicate to 
a 96-well plate with 200µl of p-nitrophenyl phosphate and incubated 
for 30 mins. The reaction was stopped by the addition of 1M NaOH 
solution and absorbance read at a wavelength of 405nm. The DNA 
content in each lysate was also measured using the PicoGreen®assay 
(described in section 2.3.4) and the ALP activity results are expressed 
per mg of DNA.  
Statistics 
Differences between materials and between time points were 
analysed using one-way ANOVA with post hoc Bonferroni’s 
test using SPSS v13 software. Where individual comparisons 
were performed, an independent Student’s t-test was used. 
p values <0.05 were considered significant. All data are expressed as 
mean ± standard error.
Results and Discussion 
Physicochemical characterization 
This study compared the physicochemical properties and in vitro 
biological performance of five different bone void filler materials. The 
materials tested differ considerably with respect to their granular size, 
shape, pore size and chemical composition making direct comparison 
between specific material properties difficult when assessing their 
biological performance. When using granules as fillers in a bone 
defect, it is hypothesized that interstitial space between the granules 
will create additional macropores, enabling infiltration of bone-
forming cells around the granules. Therefore, the shape and size of 
the granules is important, as it will influence the size of the interstitial 
pores. For penetration and ingrowth of bone cells, pores and pore 
interconnections greater than 100µm are required [1,12]. Metabolizing 
cells also require an oxygen source in close proximity for survival; 
therefore the ability of the bone void filler to become vascularised will 
enhance the successfulness of the implant [37]. 
Morphological analysis: Four of the materials are classified as 
predominately macroporous with pores in the range of 100 - 900µm. 
Slight variation in pore size was observed between pore size quoted 
by the manufacturer (Table 1) and those values calculated in-house 
(Table 2), owing to variation in characterisation techniques. Only 
QUB HA was classified as microporous, with pores in the range of 9 
-11µm (Table 2). It also had relatively small granules inthe range of 
0.3 to 2mm, similar to Bio Oss® and Pro-OsteonTM200R, however, 
the granule shape and type of pores differs between commercial 
materials (Table 1). This is also evident in the SEM micrographs, 
Figure 1a-e. The morphological structure of Bio Oss® and Pro-
OsteonTM200R/500R is similar to cancellous bone, whereas Bone Save® 
has a lower porosity with mainly closed macropores. The granule 
Material Bio Oss® Bone Save® Pro Osteon™ 200R Pro Osteon™ 500R
Supplier Geistlich Pharma Stryker,  Osteonics Biomet, (Interpore) Biomet, (Interpore)
Type Bovine Synthetic Coral Coral
Composition Similar to human bone (HA) 80%TCP:     20% HA HA-coated CaCO3 HA-coated CaCO3
Porosity 70 – 75% 50 – 55% 50% 65%
Pore Size (m) 100 300 – 500 180 – 220 270 – 650
Pore Type Interconnective Closed Pores Interconnective Interconnective
Shape Irregular Rounded Rounded Irregular
Granule Size (mm) 0.25 – 2 2 – 8 0.5 – 1 2 – 10
Table 1: Physicochemical material properties of commercial CaP bone void fillers according to manufacturers’ specifications.
Table 2: Morphological characterization of CaPbone void fillers measured in-house.
a, b. Calculated by image analysis (n = 20) 
c. Calculated using BET (r2 = 0.998; n = 3) 
d. Calculated by MIP Theoretical Porosity (n = 3)
Material Bio Oss® Bone Save® Pro Osteon™ 200R Pro Osteon™ 500R QUB HA
QUB HA Granule Size (mm) 0.25 – 2 2 - 8 0.5 - 1 2 – 10 0.3 - 2(φ)c
Pore Size (µm)b 200 - 900 300 - 500 150 - 220 200 - 650 9 - 11
Surface Area (m2 g-1)c 94.60 2.29 9.13 9.38 129.8
Porosityd 90.65±1.97 85.01±5.61 87.17±7.13 88.67±11.84 88.47±3.21
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shape of QUB HA (Figure 1ei) is cylindrical with closely-spaced 
honeycomb-like pores and typical pore wall thickness of 1.5 - 2µm, 
pore diameter of >12µm (Figure 1eii) and pore length of >100m 
(parallel to branch). These pores are interconnected by microperforations 
of 1 - 4µm, as characterised in a previous study 35]. According to the 
literature, this type of microporosity is unlikely to support osteogenesis 
[13]. Micropores in the range of 0.2 - 1µm are also visible in Bio Oss® (Figure 
1aii), Bone Save® (Figure 1bii) and Pro-OsteonTM 200R (Figure 1cii). 
A surface coating of fine needle-like crystal conglomerations are 
visible on Pro-OsteonTM500R (Figure 1dii) which are typical of highly 
crystalline HA. 
SBET of the bone void filler materials was measured using N2 gas 
absorption (Table 2), which takes into consideration only SBET of 
micro and mesopores. Bone Save®, Pro-OsteonTM200R and 500R were 
relatively low  with a range of 2.29 to 9.38 m2 g−1, compared to 94.60 and 
129.8 m2 g−1 for Bio Oss® and QUB HA respectively. The SBET values 
for Pro-OsteonTMand Bone Save® were higher than those (<1 m2 g−1) 
reported in the literature for synthetic sintered HA bioceramics. Bio 
Oss® was found to be in the range of natural bone mineral, reported 
to be between 87 and 100 m2 g−1. QUB HA was also higher than those 
values (17 - 82 m2 g−1) reported in the literature for non-sintered HA 
[38]. The high SBET of QUB HA can be explained by a smaller particle 
size and high density of micropores. The bulk porosity of the void filler 
were characterised using MIP. The results (Table 2) showed all the 
materials have a porosity of >85%, which was significantly higher than 
those quoted by the manufacturers (Table 1). Interestingly, the MIP 
results for Pro-OsteonTM200R and 500R have given similar porosity 
values of 87.17 ± 7.13 and 88.67 ± 11.84 respectively, despite having 
a different pore size range. In this instance, the micro/meso porosity 
may have played a role in balancing the overall porosities of the two 
materials. 
Chemical analysis: The ICP-MS showed that the main elements 
in the bone void filler materials were calcium and phosphate with 
CaP molar ratios ranging from 1.48 to 4.44 (Table 3). Human bone 
mineral has a chemical formula of Ca8.3(PO4)4..3(OH, CO3)0.3 with a CaP 
molar ratio in the range of 1.5 to 1.70 [39]. The CaP and (Ca+Mg)/P 
molar ratio of Bio Oss® and QUB HA was found to be similar to the 
stoichimetric value of human bone (Table 3). Bio Oss® was the only 
material tested that had the same composition to the mineral phase of 
human bone. The high molar ratios of 2.90 and 4.44 for Pro-OsteonTM-
200R and 500R are a result of the manufacturing process as only the 
outer surfaces of the exoskeleton has been converted to HA (Table 1); 
the bulk of the sample remains CaCO3, which is evident from the high 
calcium content found in the ICP results.
Heavy metal contaminants were found to be well below the specified 
limit of BS ISO 13779-4 and therefore not reported [40]. The presence 
of magnesium (Mg) ions in apatite structures is important as it plays a 
key role in bone metabolism; it has a marked inhibitory effect on HA 
nucleation and growth and stabilizes more acidic precursor phases 
[41]. Trace levels of Mg were found in all samples. Elevated levels of Mg 
were evident in Pro-OsteonTM 500R, resulting in a significant increase 
between CaP and (Ca+Mg)/P molar ratios from 4.44 to 5.28 (Table 3). 
The CaP molar ratio of Bone Save® corresponds to the theoretical CaP 
ratio of 1.5 for Ca3(PO4)2 materials, confirming the composition given 
by the manufacturer [32].The next most abundant metallic ion found in 
bone is sodium. High trace amounts, ~ 1.6mg/L, of Na ions were found 
Table 3: Ca/P Molar Ratio and minor components calculated from element’s atomic mass andICP-MS analysis (n = 6).
Material Bio Oss® Bone Save® Pro Osteon™ 200 Pro Osteon™ 500R QUB HA
Major Elements 
Ca/P Molar Ratioa 1.66 1.48 2.90 4.44 1.61
(Ca+Mg)/P Molar Ratioa 1.70 1.49 2.93 5.28 1.70
Minor Elements (mg/L)
Na 1.90 ± 0.09 0.91± 0.01 1.61 ± 0.11 1.98 ± 0.36 1.70 ± 0.62
Si 0.22 ± 0.05 0.56 ± 0.04 0.22 ± 0.01 0.25 ± 0.01 0.40 ± 0.05
Sr 0.07 ± 0.02 0.07 ± 0.01 2.46 ± 0.87 1.84 ± 0.08 0.15 ± 0.02
Figure 1: SEM micrographs of (a) Bio Oss (b) Bone Save (c) Pro-Osteon 200RTM (d) Pro-Osteon 500RTM and (e) QUB HA; ai-ei: Bars are 100 mm (Magnification x50); 
aii-eii: Bars are 10 mm (Magnification x1500).
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in all samples with the exception of the synthetic HA Bone Save®. Other 
trace elements that were detected at elevated levels were silicon and 
strontium, both of which are known to enhance bone metabolism [41].
Four of the five bone filler samples investigated using FTIR show 
vibrational modes corresponding to phosphate, hydroxyl and carbonate 
groups found in HA (Figure 2). The exception was Bone Save®, which 
matched those found in synthetic βTCP 31]. In the four HA samples, 
intense bands at 1010 – 1050 cm-1 (strongest in Bio Oss®, QUB HA) and 
1426 – 1465 cm-1 were assigned to ν2PO43-, and are consistent with the 
subgroup of the P63/m space group of HA [42]. Other characteristic HA 
bands were observed at 850 – 875 cm-1 corresponding to ν2CO32-and 
lower intensity bands at 975 – 990 cm-1 shouldering ν2 PO43-assigned to 
ν1 PO43- were also visible [28,42]. The CO32- bands at 1465 and 714 cm-1, 
and 1462 and 713 cm-1 in Pro-OsteonTM200R and 500R respectively had 
a much higher intensity compared to the other samples and are likely 
to belong to unreacted aragonite in the coral [43]. Only one CO32- band 
was observed in QUB HA at 1471 cm-1. In addition a broadband was 
observed at 3000 - 3500 cm-1 which was assigned to O-H stretching and 
is likely to be a result of water absorption in the sample [44].
XRD diffractograms for the five samples investigated are shown 
in Figure 3. All samples show the characteristic three peaks residing 
between 31 and 33° (2θ), representing (211), (112), (300) planes and 
a more crystalline peak at 26° (2θ) representing the (002) plane of HA 
[45]. The additional peaks were identified as belonging to unreacted 
calcite or aragonite, matched by the patterns (PDF 47-1473) and 
(PDF 41-1475) respectively. BioOss® and QUB HA were found to 
be poorly crystalline, similar to the crystallographic appearance 
of biological apatites. The sharp peaks found in the other samples 
indicate the presence of a highly crystalline material, which is a result 
of the high temperature processing conditions. The additional peaks 
in the samples were identified as corresponding to magnesium and 
β TCP phases, matching patterns (PDF 09-0169) and (PDF 47-1473) 
respectively. Rietveld refinement was applied to the diffractograms to 
characterize the phase content. The least-square refinement program 
used for Rietvel showed that all the patterns were well resolved with 
the calculated profiles. The algal-derived QUB HA was matched to the 
profile (PDF 73-0294). The phase composition was >95% HA, with 
minor phases of βTCP and other impurities (Table 3). BioOss® and 
Bone Save®  were found to have phase compositions of HA (100%) and 
Figure 2: FTIR Spectra of CaP Bone Void Fillers.
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β TCP (87.3%): HA (12.7%) respectively. The main phase in the two 
Pro-OsteonTM samples was aragonite (82.4±4.2%), with a minor phase 
of HA, which confirmed the ICP results (Table 3). 
The physicochemical results indicated that chemical composition, 
crystallinity and granule size of QUB HA were most similar to BioOss®. 
These findings support work by Turhani and Weiβenböckwho also 
investigated the cell response of a different QUB HA to BioOss® [46]. 
The main differences between QUB HA and Bio-Oss® were pore size, 
granule shape and SBET . All these factors are likely to influence cell 
response. QUB HA has long uniform-sized cylindrical shaped granules 
with open microporous extremities, whereas BioOss®  is irregular in 
shape with randomly distributed macroporosity. Gondaet al. found 
that in vivo, uniform-sized spherical granules achieved better stability 
and prognosis than irregular-shaped granules [47]. 
Biological characterization
Toxicity: Cytotoxicity of the biomaterials was measured after 72 
hrs in culture by the release of lactose dehydrogenase (LDH) which 
occurs upon cell death. No significant difference was found between 
LDH release in the control cells and those grown on the bone void 
filler materials (ANOVA, p = 0.1346) (Figure 4a). This suggests that the 
biomaterials are non-toxic to hFOBs. 
Cell viability: The optical density (O.D.) absorbance values 
measured from the XTT assay data are given in Figure 4b. A statistically 
significant increase in hFOB viability with time was observed on the 
samples with larger granule sizes, namely Bone Save® (p = 0.008) and 
Pro-OsteonTM500RTM (p = 0.014). No significant difference was observed 
with time on the BioOss®. After 7 days in culture, hFOB viability was 
significantly higher in Pro-OsteonTM500RTM and QUB HA compared 
to the other biomaterials (p<0.001). A slight increase in cell viability 
in Pro-OsteonTM500RTM compared to the cells only control is likely to 
be caused by the larger surface area of the 3D granules compared to a 
2D flat surface although this difference was not significant (p =0.078). 
Our results indicate that the microporous algal-HA wasas effective in 
Figure 3: XRD traces of CaP Bone Fillers.
Citation: Walsh PJ, Clarke SA, Nelson J, Maggs CA, Walker GM, et al. (2011) An in vitro Study to Assess the Potential of a Unique Micro porous 
Algal Derived Cap Bone Void Filler in Comparison with Clinically-Used Bone Void Fillers. J Tissue Sci Eng S1:002. doi:10.4172/2157-7552.
S1-002
Page 7 of 9
Special Issue 1 • 2011
J Tissue Sci Eng
ISSN:2157-7552 JTSE an open access journal 
supporting cell viability as that of its macroporous counterparts. This 
contradicts findings by Isaacset al. [13] who reported that microporosity 
in βTCP negatively modulates cell viability. This would suggest that 
other factors such as SBET , particle size and chemical composition also 
heavily influence the cellular response. For example, the algal-HA we 
tested was found to have a significantly higher SBET  of 129.8 m2 g−1, than 
that of those tested by Isaacs et al. who reported their materials to have 
SBET  of 0.001 to 1.73m2 g−1.
Cell proliferation: The proliferative ability of hFOB 
cells on the samples was determined by picogreen assay 
(Figure 4c). At day 1, the cell activity was low in all groups. Between day 
1 and day 7, the number of cells in all groups increased significantly, 
indicating that the biomaterials support proliferation. hFOBs showed 
the best proliferative capacity on Pro-Osteon 500RTM in comparison 
to the other bone void filler materials. At day 3, no significant 
difference was observed between any of the materials or cell controls 
(ANOVA, p  =0.101). At day 7, no significant difference was found 
between Bone Save® and Pro-OsteonTM500RTM, and the cells-only 
control (p = 0.145, p = 0.127). However, the proliferative capacity of 
hFOBs on QUB HA increased significantly compared to Bio-Oss® 
and Pro-OsteonTM200R. When comparing the smaller granules at 7 
days, QUB HA showed a better proliferative capacity. Interestingly, 
proliferation was significantly lower on Pro-Osteon 200RTM  compared 
to Pro-OsteonTM500RTM at day 7, despite having a similar chemical 
composition (Table 2). This indicates that particle size has a significant 
influence on cell behaviour in vitro and supports work by Weiβ enböck 
et al., who found that particle size and substrate geometry significantly 
influenced cell signaling [30]. 
Cell differentiation: ALP is one of the most common markers of 
osteogenic differentiation. ALP activity is expressed as ALP/mg DNA 
giving the ALP activity per cell, to adjust for significant differences in 
cell numbers between groups (Figure 4d). A significantly higher level 
of ALP activity was found between day 3 and 7, with the exception 
of QUB HA indicating that the cells may differentiate earlier on QUB 
HA.No significant differences were found in the level of ALP activity 
between BioOss®, Bone Save®, Pro-OsteonTM 500R and QUB HA at 
day 7 (p=0.397). Pro-OsteonTM200R showed a significant increase 
in ALP activity when compared to these groups, but no significanct 
difference when compared to the cells-only control (p=0.131). The 
physicochemical results showed that QUB HA was most similar to Bio-
Oss®, however the cell analysis showed that QUB HA supported more 
cell growth at 7 days and more ALPat day 3.
ALP activity was low on all materials when compared to the cells-
only controls after 7 days with the exception of Pro-OsteonTM200R. 
These results, in conjunction with those for cell proliferation, suggest 
that hFOBs on Pro-OsteonTM200R differentiate earlier than those on 
the other materials. As cells differentiate, their proliferative capacity 
decreases, therefore the delayed differentiation seen on all other 
materials could contribute to the increase in cell number found on Pro-
OsteonTM500R, Bone Save and QUB HA.
In vitro results: The results showed that cells maintain their function 
on the microporous QUB HA with similar or better biocompatibility 
than the clinically available bone void fillers tested. In our in vitro 
studies, instability of bone void fillers could have caused disruption 
to the cell monolayer formation, thus affecting cell attachment and 
proliferation butthe rationale of testing the fillers without a fixative 
agent (e.g. fibrin glue) was to ensure that the cell response was a direct 
result of the filler. The use of fixatives also had the potential toblock 
pores, thus reducing the topographical effect of the fillers.
Figure 4: Biological Evaluation (a) LDH Cytotoxicity Assay (b) Optical 
density measurements for XTT cell viability assay as a function of time (c) 
Cell proliferation assay incubated at 33°C and (d) ALP Activity normalized to 
DNA (Picogreen Assay) at 39°C.
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Some studies have suggested that larger microporous surface 
areas increase protein adsorption, enhancing cell attachment [48], 
however others have argued that protein adsorption does not enhance 
cell attachment but promotes inducible cells to differentiate down the 
osteogenic lineage [10]. The SBET was significantly higher, 129.8 m2 g−1 
for QUB HA, compared to 94.60 m2 g−1 for Bio Oss®and we found that 
there was an increase in proliferation on QUB HA but similar levels of 
ALP expression, suggesting the former effect is more likely. 
Our results also suggestthat granule size has a significant effect on 
the cellular response. By comparing Pro-OsteonTM 200R to 500RTM it 
is possible to assess the influence of different granule sizes on cellular 
behaviour. The physicochemical data showed that Pro-OsteonTM 
200R and 500RTM have the same pore size, surface area and chemical 
composition but differ in size of granule (Table 2) however; the 
biochemical results have shown a significantly higher proliferation of 
cells on Pro-OsteonTM500R compared to 200R, whereas differentiation 
was significantly lower in Pro-OsteonTM500R compared to Pro-
OsteonTM200R. This may be directly related to the granule size but it 
is important to note that, although Rietveld analysis quantified the 
materials with the same phase composition, ICP analysis (Table 3) 
found elevated levels of Mg in Pro-OsteonTM500R. Other studies have 
shown that Mg enhances osteoconductivity by stimulating better cell 
adhesion and proliferation, andcould also account for the increased 
cell number [20]. All materials tested were HA, with the exception of 
Bone Save® which was predominantly βTCP with a minor HA phase. 
This, and other studies, have shown that the manufacturing process 
used to fabricate bioceramics strongly influences chemistry and pore 
geometries and thus the cellular response. 
Conclusion
This was a pilot study to assess a novel sustainable microporous 
algal HA bioceramic as potential bone void filler. Outcome measures 
were the ability to support proliferation and differentiation of hFOB 
cells. It was hypothesized that microporous granules would perform 
equally to macroporosity in terms of the biological response. 
Although direct comparison between micro and macro scale porosity 
was difficult due to other chemical and physical variation between 
materials, the results have clearly shown that the algal-HA (QUB HA) 
is capable of supporting cellular activity. QUB HA exhibited a similar 
rate of osteogenic differentiation to all other biomaterials tested, with 
the exception of Pro-OsteonTM 200R. It also showed an increased rate 
of proliferation and cell viability compared to the other biomaterials, 
with the exception of Pro-OsteonTM 500R. One possible explanation 
is that the interstitial macroporous space between QUB HA granules 
has provided sufficient interstitial space for cells to penetrate between 
the granules and fulfil their functions, however this theory needs to 
be tested in vivo. Our results have clearly shown that HA granules 
with an interconnected microporous morphology, which provides a 
high surface area, positively supports cell viability, proliferation and 
differentiation. Furthermore the results suggest that other factors, such 
as granule size, specific surface area and surface chemistry, are equally 
as important as pore size in tissue regeneration. The next stage of this 
work will focus on in vitro bioresorption profiling of these materials 
followed by in vivo trials. 
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